Integrated Oncology (United States)

InstitutionResearch output, impact & collaborations

Integrated Oncology (United States) is a research organisation in Durham, US. OpenAlex records 2,629 works and 255,967 citations for it. 1,024 researchers list it as their most recent affiliation.

2,629

Works

255,967

Citations

1,024

Researchers

80.3

Avg h-index

IDs:ROR OpenAlex

How has Integrated Oncology (United States)'s publication output changed over time?

ScholarIQpublication output · 2011–2017

Output grew0% over the shown period — from 1 works in 2011 to 1 in 2017.

201120142017

What are the most-cited papers on Integrated Oncology (United States)?

ScholarIQmost cited works

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial

Martin Reck, R. Kaiser, Anders Mellemgaard, Jean‐Yves Douillard, С. В. Орлов, Maciej Krzakowski, Joachim von Pawel, Maya Gottfried, Igor Bondarenko, Meilin Liao, Claudia-Nanette Gann, José Barrueco, Birgit Gaschler‐Markefski, Silvia Novello

The Lancet Oncology. 2014950 CitationsOPEN ACCESS

Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS

Takayuki Yoshino, Dirk Arnold, Hiroya Taniguchi, George Pentheroudakis, Kentaro Yamazaki, Rui‐Hua Xu, Tae‐Woo Kim, Muhammad Ismail, Iain Tan, Kun‐Huei Yeh, Axel Grothey, S. Zhang, Joong Bae Ahn, M.Y. Mastura, Dawn Q. Chong, Liqun Chen, Scott Kopetz, Takako Eguchi-Nakajima, Hiromichi Ebi, Atsushi Ohtsu, Andrés Cervantes, Kei Muro, Josep Tabernero, Hironobu Minami, Fortunato Ciardiello, Jean‐Yves Douillard

Annals of Oncology. 2017596 CitationsOPEN ACCESS

Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer

Primo N. Lara, Jean‐Yves Douillard, Kazuhiko Nakagawa, Joachim von Pawel, Mark J. McKeage, István Albert, György Losonczy, Martin Reck, Dae Seog Heo, Xiaolin Fan, Abderrahim Fandi, Giorgio V. Scagliotti

Journal of Clinical Oncology. 2011321 CitationsOPEN ACCESS